Global and Japan Lancets Market Insights, Forecast to 2027

Publisher Name :
Date: 01-Sep-2021
No. of pages: 166
Inquire Before Buying

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.

These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

The major players in global Lancets market include Roche, Lifescan, BD, etc. The top 3 players occupy about 30% shares of the global market. Europe and North America are main markets, they occupy about 70% of the global market. Homecare Lancets is the main type, with a share about 80%. Glucose Tests is the main application, which holds a share about 70%.

Market Analysis and Insights: Global and Japan Lancets Market

This report focuses on global and Japan Lancets market.

In 2020, the global Lancets market size was US$ 1661 million and it is expected to reach US$ 2522.8 million by the end of 2027, with a CAGR of 5.7% during 2021-2027. In Japan the Lancets market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Lancets Scope and Market Size

Lancets market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Lancets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For Japan market, this report focuses on the Lancets market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

- Safety Lancets

- Homecare Lancets

Segment by Application

- Cholesterol Tests

- Glucose Tests

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Roche

- Lifescan

- BD

- Bayer

- Abbott

- B. Braun

- ARKRAY

- Terumo

- I-SENS

- Nipro

- Omron

- Infopia

- AgaMatrix

- Smiths Medical

- Sarstedt

- SANNUO

- Yicheng

- Yuwell

- Greiner Bio One

- Edan

- Narang Medical

Global and Japan Lancets Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Lancets Product Introduction
1.2 Market by Type
1.2.1 Global Lancets Market Size Growth Rate by Type
1.2.2 Safety Lancets
1.2.3 Homecare Lancets
1.3 Market by Application
1.3.1 Global Lancets Market Size Growth Rate by Application
1.3.2 Cholesterol Tests
1.3.3 Glucose Tests
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Lancets Market Size, Estimates and Forecasts
2.1.1 Global Lancets Revenue 2016-2027
2.1.2 Global Lancets Sales 2016-2027
2.2 Global Lancets, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Lancets Historical Market Size by Region (2016-2021)
2.3.1 Global Lancets Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Lancets Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Lancets Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Lancets Sales Forecast by Region (2022-2027)
2.4.2 Global Lancets Revenue Forecast by Region (2022-2027)
3 Global Lancets Competitor Landscape by Players
3.1 Global Top Lancets Manufacturers by Sales
3.1.1 Global Lancets Sales by Manufacturer (2016-2021)
3.1.2 Global Lancets Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Lancets Manufacturers by Revenue
3.2.1 Key Lancets Manufacturers Covered: Ranking by Revenue
3.2.2 Global Lancets Revenue by Manufacturers (2016-2021)
3.2.3 Global Lancets Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Lancets Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Lancets Revenue in 2020
3.2.6 Global Lancets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Lancets Price by Manufacturers
3.4 Global Lancets Manufacturing Base Distribution, Product Types
3.4.1 Lancets Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Lancets Product Type
3.4.3 Date of International Manufacturers Enter into Lancets Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Lancets Market Size by Type (2016-2021)
4.1.1 Global Lancets Sales by Type (2016-2021)
4.1.2 Global Lancets Revenue by Type (2016-2021)
4.1.3 Lancets Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Lancets Market Size Forecast by Type (2022-2027)
4.2.1 Global Lancets Sales Forecast by Type (2022-2027)
4.2.2 Global Lancets Revenue Forecast by Type (2022-2027)
4.2.3 Lancets Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Lancets Market Size by Application (2016-2021)
5.1.1 Global Lancets Sales by Application (2016-2021)
5.1.2 Global Lancets Revenue by Application (2016-2021)
5.1.3 Lancets Price by Application (2016-2021)
5.2 Lancets Market Size Forecast by Application (2022-2027)
5.2.1 Global Lancets Sales Forecast by Application (2022-2027)
5.2.2 Global Lancets Revenue Forecast by Application (2022-2027)
5.2.3 Global Lancets Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Lancets Market Size YoY Growth 2016-2027
6.1.1 Japan Lancets Sales YoY Growth 2016-2027
6.1.2 Japan Lancets Revenue YoY Growth 2016-2027
6.1.3 Japan Lancets Market Share in Global Market 2016-2027
6.2 Japan Lancets Market Size by Players (International and Local Players)
6.2.1 Japan Top Lancets Players by Sales (2016-2021)
6.2.2 Japan Top Lancets Players by Revenue (2016-2021)
6.3 Japan Lancets Historic Market Review by Type (2016-2021)
6.3.1 Japan Lancets Sales Market Share by Type (2016-2021)
6.3.2 Japan Lancets Revenue Market Share by Type (2016-2021)
6.3.3 Japan Lancets Price by Type (2016-2021)
6.4 Japan Lancets Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Lancets Sales Forecast by Type (2022-2027)
6.4.2 Japan Lancets Revenue Forecast by Type (2022-2027)
6.4.3 Japan Lancets Price Forecast by Type (2022-2027)
6.5 Japan Lancets Historic Market Review by Application (2016-2021)
6.5.1 Japan Lancets Sales Market Share by Application (2016-2021)
6.5.2 Japan Lancets Revenue Market Share by Application (2016-2021)
6.5.3 Japan Lancets Price by Application (2016-2021)
6.6 Japan Lancets Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Lancets Sales Forecast by Application (2022-2027)
6.6.2 Japan Lancets Revenue Forecast by Application (2022-2027)
6.6.3 Japan Lancets Price Forecast by Application (2022-2027)
7 North America
7.1 North America Lancets Market Size YoY Growth 2016-2027
7.2 North America Lancets Market Facts & Figures by Country
7.2.1 North America Lancets Sales by Country (2016-2021)
7.2.2 North America Lancets Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Lancets Market Size YoY Growth 2016-2027
8.2 Asia Pacific Lancets Market Facts & Figures by Region
8.2.1 Asia Pacific Lancets Sales by Region (2016-2021)
8.2.2 Asia Pacific Lancets Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Lancets Market Size YoY Growth 2016-2027
9.2 Europe Lancets Market Facts & Figures by Country
9.2.1 Europe Lancets Sales by Country (2016-2021)
9.2.2 Europe Lancets Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Lancets Market Size YoY Growth 2016-2027
10.2 Latin America Lancets Market Facts & Figures by Country
10.2.1 Latin America Lancets Sales by Country (2016-2021)
10.2.2 Latin America Lancets Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Lancets Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Lancets Market Facts & Figures by Country
11.2.1 Middle East and Africa Lancets Sales by Country (2016-2021)
11.2.2 Middle East and Africa Lancets Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Description and Business Overview
12.1.3 Roche Lancets Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Lancets Products Offered
12.1.5 Roche Recent Development
12.2 Lifescan
12.2.1 Lifescan Corporation Information
12.2.2 Lifescan Description and Business Overview
12.2.3 Lifescan Lancets Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Lifescan Lancets Products Offered
12.2.5 Lifescan Recent Development
12.3 BD
12.3.1 BD Corporation Information
12.3.2 BD Description and Business Overview
12.3.3 BD Lancets Sales, Revenue and Gross Margin (2016-2021)
12.3.4 BD Lancets Products Offered
12.3.5 BD Recent Development
12.4 Bayer
12.4.1 Bayer Corporation Information
12.4.2 Bayer Description and Business Overview
12.4.3 Bayer Lancets Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bayer Lancets Products Offered
12.4.5 Bayer Recent Development
12.5 Abbott
12.5.1 Abbott Corporation Information
12.5.2 Abbott Description and Business Overview
12.5.3 Abbott Lancets Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Abbott Lancets Products Offered
12.5.5 Abbott Recent Development
12.6 B. Braun
12.6.1 B. Braun Corporation Information
12.6.2 B. Braun Description and Business Overview
12.6.3 B. Braun Lancets Sales, Revenue and Gross Margin (2016-2021)
12.6.4 B. Braun Lancets Products Offered
12.6.5 B. Braun Recent Development
12.7 ARKRAY
12.7.1 ARKRAY Corporation Information
12.7.2 ARKRAY Description and Business Overview
12.7.3 ARKRAY Lancets Sales, Revenue and Gross Margin (2016-2021)
12.7.4 ARKRAY Lancets Products Offered
12.7.5 ARKRAY Recent Development
12.8 Terumo
12.8.1 Terumo Corporation Information
12.8.2 Terumo Description and Business Overview
12.8.3 Terumo Lancets Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Terumo Lancets Products Offered
12.8.5 Terumo Recent Development
12.9 I-SENS
12.9.1 I-SENS Corporation Information
12.9.2 I-SENS Description and Business Overview
12.9.3 I-SENS Lancets Sales, Revenue and Gross Margin (2016-2021)
12.9.4 I-SENS Lancets Products Offered
12.9.5 I-SENS Recent Development
12.10 Nipro
12.10.1 Nipro Corporation Information
12.10.2 Nipro Description and Business Overview
12.10.3 Nipro Lancets Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Nipro Lancets Products Offered
12.10.5 Nipro Recent Development
12.11 Roche
12.11.1 Roche Corporation Information
12.11.2 Roche Description and Business Overview
12.11.3 Roche Lancets Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Roche Lancets Products Offered
12.11.5 Roche Recent Development
12.12 Infopia
12.12.1 Infopia Corporation Information
12.12.2 Infopia Description and Business Overview
12.12.3 Infopia Lancets Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Infopia Products Offered
12.12.5 Infopia Recent Development
12.13 AgaMatrix
12.13.1 AgaMatrix Corporation Information
12.13.2 AgaMatrix Description and Business Overview
12.13.3 AgaMatrix Lancets Sales, Revenue and Gross Margin (2016-2021)
12.13.4 AgaMatrix Products Offered
12.13.5 AgaMatrix Recent Development
12.14 Smiths Medical
12.14.1 Smiths Medical Corporation Information
12.14.2 Smiths Medical Description and Business Overview
12.14.3 Smiths Medical Lancets Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Smiths Medical Products Offered
12.14.5 Smiths Medical Recent Development
12.15 Sarstedt
12.15.1 Sarstedt Corporation Information
12.15.2 Sarstedt Description and Business Overview
12.15.3 Sarstedt Lancets Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Sarstedt Products Offered
12.15.5 Sarstedt Recent Development
12.16 SANNUO
12.16.1 SANNUO Corporation Information
12.16.2 SANNUO Description and Business Overview
12.16.3 SANNUO Lancets Sales, Revenue and Gross Margin (2016-2021)
12.16.4 SANNUO Products Offered
12.16.5 SANNUO Recent Development
12.17 Yicheng
12.17.1 Yicheng Corporation Information
12.17.2 Yicheng Description and Business Overview
12.17.3 Yicheng Lancets Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Yicheng Products Offered
12.17.5 Yicheng Recent Development
12.18 Yuwell
12.18.1 Yuwell Corporation Information
12.18.2 Yuwell Description and Business Overview
12.18.3 Yuwell Lancets Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Yuwell Products Offered
12.18.5 Yuwell Recent Development
12.19 Greiner Bio One
12.19.1 Greiner Bio One Corporation Information
12.19.2 Greiner Bio One Description and Business Overview
12.19.3 Greiner Bio One Lancets Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Greiner Bio One Products Offered
12.19.5 Greiner Bio One Recent Development
12.20 Edan
12.20.1 Edan Corporation Information
12.20.2 Edan Description and Business Overview
12.20.3 Edan Lancets Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Edan Products Offered
12.20.5 Edan Recent Development
12.21 Narang Medical
12.21.1 Narang Medical Corporation Information
12.21.2 Narang Medical Description and Business Overview
12.21.3 Narang Medical Lancets Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Narang Medical Products Offered
12.21.5 Narang Medical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Lancets Industry Trends
13.2 Lancets Market Drivers
13.3 Lancets Market Challenges
13.4 Lancets Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Lancets Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Lancets Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Safety Lancets
Table 3. Major Manufacturers of Homecare Lancets
Table 4. Global Lancets Market Size Growth Rate by Application (2021-2027) & (M Units)
Table 5. Global Lancets Market Size by Region (M Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Lancets Sales by Regions (2016-2021) & (M Units)
Table 7. Global Lancets Sales Market Share by Regions (2016-2021)
Table 8. Global Lancets Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Lancets Sales Forecast by Region (2022-2027) & (M Units)
Table 10. Global Lancets Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Lancets Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Lancets Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Lancets Sales by Manufacturers (2016-2021) (M Units)
Table 14. Global Lancets Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Lancets Manufacturers by Revenue (US$ Million) in 2020
Table 16. Lancets Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Lancets Revenue Share by Manufacturers (2016-2021)
Table 18. Global Lancets Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Lancets by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lancets as of 2020)
Table 20. Key Manufacturers Lancets Price (2016-2021) (US$/K Units)
Table 21. Lancets Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Lancets Product Type
Table 23. Date of International Manufacturers Enter into Lancets Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Lancets Sales by Type (2016-2021) (M Units)
Table 26. Global Lancets Sales Share by Type (2016-2021)
Table 27. Global Lancets Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Lancets Revenue Share by Type (2016-2021)
Table 29. Lancets Average Selling Price (ASP) by Type (2016-2021) & (US$/K Units)
Table 30. Global Lancets Sales Forecast by Type (2022-2027) & (M Units)
Table 31. Global Lancets Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Lancets Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Lancets Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Lancets Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/K Units)
Table 35. Global Lancets Sales by Application (2016-2021) (M Units)
Table 36. Global Lancets Sales Share by Application (2016-2021)
Table 37. Global Lancets Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Lancets Revenue Share by Application (2016-2021)
Table 39. Lancets Average Selling Price (ASP) by Application (2016-2021) & (US$/K Units)
Table 40. Global Lancets Sales Forecast by Application (2022-2027) & (M Units)
Table 41. Global Lancets Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Lancets Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Lancets Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Lancets Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/K Units)
Table 45. Japan Lancets Sales (M Units) of Key Companies (2016-2021)
Table 46. Japan Lancets Sales Share by Company (2016-2021)
Table 47. Japan Lancets Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Lancets Revenue Share by Company (2016-2021)
Table 49. Japan Lancets Sales (M Units) by Type (2016-2021)
Table 50. Japan Lancets Sales Share by Type (2016-2021)
Table 51. Japan Lancets Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Lancets Price (US$/K Units) by Type (2016-2021)
Table 53. Japan Lancets Sales (M Units) by Type (2022-2027)
Table 54. Japan Lancets Sales Share by Type (2022-2027)
Table 55. Japan Lancets Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Lancets Revenue Share by Type (2022-2027)
Table 57. Japan Lancets Price (US$/K Units) by Type (2022-2027)
Table 58. Japan Lancets Sales (M Units) by Application (2016-2021)
Table 59. Japan Lancets Sales Share by Application (2016-2021)
Table 60. Japan Lancets Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Lancets Price (US$/K Units) by Application (2016-2021)
Table 62. Japan Lancets Sales (M Units) by Application (2022-2027)
Table 63. Japan Lancets Sales Share by Application (2022-2027)
Table 64. Japan Lancets Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Lancets Revenue Share by Application (2022-2027)
Table 66. Japan Lancets Price (US$/K Units) by Application (2022-2027)
Table 67. North America Lancets Sales by Country (2016-2021) & (M Units)
Table 68. North America Lancets Sales Market Share by Country (2016-2021)
Table 69. North America Lancets Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Lancets Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Lancets Sales by Region (2016-2021) & (M Units)
Table 72. Asia Pacific Lancets Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Lancets Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Lancets Revenue Market Share by Region (2016-2021)
Table 75. Europe Lancets Sales by Country (2016-2021) & (M Units)
Table 76. Europe Lancets Sales Market Share by Country (2016-2021)
Table 77. Europe Lancets Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Lancets Revenue Market Share by Country (2016-2021)
Table 79. Latin America Lancets Sales by Country (2016-2021) & (M Units)
Table 80. Latin America Lancets Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Lancets Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Lancets Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Lancets Sales by Country (2016-2021) & (M Units)
Table 84. Middle East and Africa Lancets Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Lancets Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Lancets Revenue Market Share by Country (2016-2021)
Table 87. Roche Corporation Information
Table 88. Roche Description and Business Overview
Table 89. Roche Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 90. Roche Lancets Product
Table 91. Roche Recent Development
Table 92. Lifescan Corporation Information
Table 93. Lifescan Description and Business Overview
Table 94. Lifescan Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 95. Lifescan Product
Table 96. Lifescan Recent Development
Table 97. BD Corporation Information
Table 98. BD Description and Business Overview
Table 99. BD Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 100. BD Product
Table 101. BD Recent Development
Table 102. Bayer Corporation Information
Table 103. Bayer Description and Business Overview
Table 104. Bayer Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 105. Bayer Product
Table 106. Bayer Recent Development
Table 107. Abbott Corporation Information
Table 108. Abbott Description and Business Overview
Table 109. Abbott Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 110. Abbott Product
Table 111. Abbott Recent Development
Table 112. B. Braun Corporation Information
Table 113. B. Braun Description and Business Overview
Table 114. B. Braun Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 115. B. Braun Product
Table 116. B. Braun Recent Development
Table 117. ARKRAY Corporation Information
Table 118. ARKRAY Description and Business Overview
Table 119. ARKRAY Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 120. ARKRAY Product
Table 121. ARKRAY Recent Development
Table 122. Terumo Corporation Information
Table 123. Terumo Description and Business Overview
Table 124. Terumo Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 125. Terumo Product
Table 126. Terumo Recent Development
Table 127. I-SENS Corporation Information
Table 128. I-SENS Description and Business Overview
Table 129. I-SENS Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 130. I-SENS Product
Table 131. I-SENS Recent Development
Table 132. Nipro Corporation Information
Table 133. Nipro Description and Business Overview
Table 134. Nipro Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 135. Nipro Product
Table 136. Nipro Recent Development
Table 137. Omron Corporation Information
Table 138. Omron Description and Business Overview
Table 139. Omron Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 140. Omron Product
Table 141. Omron Recent Development
Table 142. Infopia Corporation Information
Table 143. Infopia Description and Business Overview
Table 144. Infopia Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 145. Infopia Product
Table 146. Infopia Recent Development
Table 147. AgaMatrix Corporation Information
Table 148. AgaMatrix Description and Business Overview
Table 149. AgaMatrix Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 150. AgaMatrix Product
Table 151. AgaMatrix Recent Development
Table 152. Smiths Medical Corporation Information
Table 153. Smiths Medical Description and Business Overview
Table 154. Smiths Medical Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 155. Smiths Medical Product
Table 156. Smiths Medical Recent Development
Table 157. Sarstedt Corporation Information
Table 158. Sarstedt Description and Business Overview
Table 159. Sarstedt Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 160. Sarstedt Product
Table 161. Sarstedt Recent Development
Table 162. SANNUO Corporation Information
Table 163. SANNUO Description and Business Overview
Table 164. SANNUO Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 165. SANNUO Product
Table 166. SANNUO Recent Development
Table 167. Yicheng Corporation Information
Table 168. Yicheng Description and Business Overview
Table 169. Yicheng Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 170. Yicheng Product
Table 171. Yicheng Recent Development
Table 172. Yuwell Corporation Information
Table 173. Yuwell Description and Business Overview
Table 174. Yuwell Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 175. Yuwell Product
Table 176. Yuwell Recent Development
Table 177. Greiner Bio One Corporation Information
Table 178. Greiner Bio One Description and Business Overview
Table 179. Greiner Bio One Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 180. Greiner Bio One Product
Table 181. Greiner Bio One Recent Development
Table 182. Edan Corporation Information
Table 183. Edan Description and Business Overview
Table 184. Edan Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 185. Edan Product
Table 186. Edan Recent Development
Table 187. Narang Medical Corporation Information
Table 188. Narang Medical Description and Business Overview
Table 189. Narang Medical Lancets Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2016-2021)
Table 190. Narang Medical Product
Table 191. Narang Medical Recent Development
Table 192. Lancets Market Trends
Table 193. Lancets Market Drivers
Table 194. Lancets Market Challenges
Table 195. Lancets Market Restraints
Table 196. Lancets Customers List
Table 197. Lancets Distributors List
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Lancets Product Picture
Figure 2. Global Lancets Sales Market Share by Type in 2020 & 2027
Figure 3. Safety Lancets Product Picture
Figure 4. Homecare Lancets Product Picture
Figure 5. Global Lancets Sales Market Share by Application in 2020 & 2027
Figure 6. Cholesterol Tests
Figure 7. Glucose Tests
Figure 8. Others
Figure 9. Lancets Report Years Considered
Figure 10. Global Lancets Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Lancets Market Size 2016-2027 (US$ Million)
Figure 12. Global Lancets Sales 2016-2027 (M Units)
Figure 13. Global Lancets Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Lancets Sales Market Share by Region (2016-2021)
Figure 15. Global Lancets Sales Market Share by Region in 2020
Figure 16. Global Lancets Revenue Market Share by Region (2016-2021)
Figure 17. Global Lancets Revenue Market Share by Region in 2020
Figure 18. Global Lancets Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Lancets Revenue in 2020
Figure 20. Lancets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Lancets Sales Market Share by Type (2016-2021)
Figure 22. Global Lancets Sales Market Share by Type in 2020
Figure 23. Global Lancets Revenue Market Share by Type (2016-2021)
Figure 24. Global Lancets Revenue Market Share by Type in 2020
Figure 25. Global Lancets Sales Market Share by Application (2016-2021)
Figure 26. Global Lancets Sales Market Share by Application in 2020
Figure 27. Global Lancets Revenue Market Share by Application (2016-2021)
Figure 28. Global Lancets Revenue Market Share by Application in 2020
Figure 29. Japan Lancets Sales Growth Rate 2016-2027 (M Units)
Figure 30. Japan Lancets Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. Japan Lancets Market Share in Global Market 2016-2027
Figure 32. Japan 5 and 10 Largest Lancets Players Market Share by Revenue in Lancets in 2020
Figure 33. Japan Lancets Revenue Share by Type (2016-2021)
Figure 34. Japan Lancets Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Japan Lancets Revenue Share by Application (2016-2021)
Figure 36. Japan Lancets Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Lancets Sales Growth Rate 2016-2021 (M Units)
Figure 38. North America Lancets Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Lancets Sales Market Share by Country in 2020
Figure 40. North America Lancets Revenue Market Share by Country in 2020
Figure 41. U.S. Lancets Sales Growth Rate (2016-2021) (M Units)
Figure 42. U.S. Lancets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Lancets Sales Growth Rate (2016-2021) (M Units)
Figure 44. Canada Lancets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Lancets Sales Growth Rate 2016-2021 (M Units)
Figure 46. Europe Lancets Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Lancets Sales Market Share by Country in 2020
Figure 48. Europe Lancets Revenue Market Share by Country in 2020
Figure 49. Germany Lancets Sales Growth Rate (2016-2021) (M Units)
Figure 50. Germany Lancets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Lancets Sales Growth Rate (2016-2021) (M Units)
Figure 52. France Lancets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Lancets Sales Growth Rate (2016-2021) (M Units)
Figure 54. U.K. Lancets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Lancets Sales Growth Rate (2016-2021) (M Units)
Figure 56. Italy Lancets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Lancets Sales Growth Rate (2016-2021) (M Units)
Figure 58. Russia Lancets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Lancets Sales Growth Rate 2016-2021 (M Units)
Figure 60. Asia Pacific Lancets Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Lancets Sales Market Share by Region in 2020
Figure 62. Asia Pacific Lancets Revenue Market Share by Region in 2020
Figure 63. China Lancets Sales Growth Rate (2016-2021) (M Units)
Figure 64. China Lancets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Lancets Sales Growth Rate (2016-2021) (M Units)
Figure 66. Japan Lancets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Lancets Sales Growth Rate (2016-2021) (M Units)
Figure 68. South Korea Lancets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Lancets Sales Growth Rate (2016-2021) (M Units)
Figure 70. India Lancets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Lancets Sales Growth Rate (2016-2021) (M Units)
Figure 72. Australia Lancets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. China Taiwan Lancets Sales Growth Rate (2016-2021) (M Units)
Figure 74. China Taiwan Lancets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Lancets Sales Growth Rate (2016-2021) (M Units)
Figure 76. Indonesia Lancets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Lancets Sales Growth Rate (2016-2021) (M Units)
Figure 78. Thailand Lancets Revenue Growth R
  • Global Non-Invasive Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 79
    This report studies The Non-Invasive Glucose Meter market. Noninvasive glucose monitoring refers to The measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from The disease) without drawing blood, puncturing The skin, or causing pain or trauma. The global Non-Invasive Glucose Meter market was valued at US$ 179.5 million in 2023 and is anticipated to reach US$ 271.2 million by 2030, witnessing a CAGR of 6.0% during The......
  • Global Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 106
    Glucose Meter is a medical device for determining The approximate concentration of glucose in The blood. It can also be a strip of glucose paper dipped into a substance and measured to The glucose chart. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking The skin with a lancet, is placed on a disposable test strip that The meter reads and uses to calculate The blood glucose level. The meter the......
  • Global Blood Glucose Testing Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 101
    Blood glucose testing, also known as blood glucose monitoring, is one of The main tools involved in controlling diabetes. Blood glucose testing is The process used to measure The concentration of glucose in your blood. Blood glucose testing can be carried out at home using a blood glucose meter. A blood test involves pricking your finger with a small needle called a lancet, drawing a drop of blood from The finger and applying it to a test strip that has been engaged into a blood gluc......
  • Global Glucose Biosensors Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139
    According to our LPI (LP Information) latest study, the global Glucose Biosensors market size was valued at US$ 3249.7 million in 2023. With growing demand in downstream market, the Glucose Biosensors is forecast to a readjusted size of US$ 3620.7 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Glucose Biosensors market. Glucose Biosensors are expected to show stable growth in the future market. However, product ......
  • Global Artificial Pancreas Devices Systems Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Artificial Pancreas Devices Systems market size was valued at US$ 87 million in 2023. With growing demand in downstream market, the Artificial Pancreas Devices Systems is forecast to a readjusted size of US$ 199.2 million by 2030 with a CAGR of 12.6% during review period. The research report highlights the growth potential of the global Artificial Pancreas Devices Systems market. Artificial Pancreas Devices Systems are expect......
  • Global Blood Glucose Testing Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 130
    According to our LPI (LP Information) latest study, the global Blood Glucose Testing market size was valued at US$ 10710 million in 2023. With growing demand in downstream market, the Blood Glucose Testing is forecast to a readjusted size of US$ 13370 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Blood Glucose Testing market. Blood Glucose Testing are expected to show stable growth in the future market. However......
  • Global Lancing Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Lancing Devices market size was valued at US$ 315 million in 2023. With growing demand in downstream market, the Lancing Devices is forecast to a readjusted size of US$ 439.6 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Lancing Devices market. Lancing Devices are expected to show stable growth in the future market. However, product differentiation,......
  • Global Non-Invasive Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Non-Invasive Glucose Meter market size was valued at US$ 175.6 million in 2023. With growing demand in downstream market, the Non-Invasive Glucose Meter is forecast to a readjusted size of US$ 268 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Non-Invasive Glucose Meter market. Non-Invasive Glucose Meter are expected to show stable growth in the futu......
  • Global Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Glucose Meter market size was valued at US$ 1258 million in 2023. With growing demand in downstream market, the Glucose Meter is forecast to a readjusted size of US$ 1959.5 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Glucose Meter market. Glucose Meter are expected to show stable growth in the future market. However, product differentiation, reduc......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs